Amgen Singapore Manufacturing: A Look into the Biotech Company’s Production in Asia
Welcome to the world of biomanufacturing in Asia, where Amgen Singapore Manufacturing is leading the way. As one of the world’s first biomanufacturing facilities using a combination of innovative flexible technologies, Amgen Singapore Manufacturing is making a significant impact on biotechnology in the region.
Amgen’s impact on biomanufacturing in Asia is undeniable. With over three decades of experience in the development and use of manufacturing technologies, Amgen is setting the standard for the future. The company’s investment of more than US$150 million in its Next-Generation Biomanufacturing facility is a testament to its commitment to providing medicines that treat serious diseases in an efficient and innovative way.
At Amgen Singapore Manufacturing, the patient is at the heart of everything they do. The company’s local footprint reinforces its commitment to the community and is a testament to Singapore’s strong track record for best-in-class biopharmaceutical manufacturing. To-date, Amgen has invested more than SGD$400 million into its Singapore operations, making significant economic contributions to the region.
Key Takeaways
- Amgen Singapore Manufacturing is leading the way in biomanufacturing in Asia.
- The company’s investment in innovative flexible technologies is setting the standard for the future.
- Amgen’s commitment to the patient and the community is reflected in its significant economic contributions to the region.
Amgen’s Impact on Biomanufacturing in Asia
If you’re interested in biomanufacturing in Asia, you can’t ignore Amgen’s impact. Amgen is a leading biotechnology company that has made significant contributions to the field of human therapeutics. With its state-of-the-art Next-Generation Biomanufacturing facility in Tuas Biomedical Park, Singapore, Amgen has expanded its presence in the Asia Pacific region and introduced innovative technologies that have revolutionized biologics production.
Expansion in Asia Pacific Region
Amgen’s investment in Singapore’s biomanufacturing industry has been a game-changer. Its Next-Generation Biomanufacturing facility is the company’s first manufacturing site in Asia and is aimed at increasing production capabilities and allowing greater accessibility to patients around the world. This expansion has not only created job opportunities in the region, but it has also contributed to the growth of the biomanufacturing industry in Asia.
Innovations in Biologics Production
Amgen has introduced modular and flexible technologies that have made biologics production more efficient and productive. The company’s Next-Generation Biomanufacturing facility utilizes single-use bioreactors, disposable plastic containers, continuous purification processing, and real-time quality analysis. These innovations have not only improved efficiency and productivity but have also made biologics production more sustainable by reducing energy and water consumption.
Sustainability and Efficiency
Amgen’s commitment to sustainability and efficiency is evident in its Next-Generation Biomanufacturing facility. The facility has been designed to be energy-efficient, with features such as solar panels, energy-efficient lighting, and a rainwater harvesting system. The facility also boasts a state-of-the-art wastewater treatment system that ensures the safe disposal of waste.
In conclusion, Amgen’s impact on biomanufacturing in Asia has been significant. Its innovative technologies, commitment to sustainability and efficiency, and expansion in the Asia Pacific region have contributed to the growth of the biomanufacturing industry in the region.
Community and Economic Contributions
As a leading biopharmaceutical company, Amgen Singapore Manufacturing is committed to making significant contributions to the community and the economy. Here are some of the ways in which Amgen Singapore is making a positive impact:
Job Creation and Workforce Development
Amgen Singapore Manufacturing’s investment in Singapore is aligned with the Economic Development Board’s focus on developing higher-value-added sectors that can provide quality jobs and careers for the Singaporean workforce, especially within the biomedical industry. The company has created numerous job opportunities for locals and has invested in workforce development to ensure that its employees have the skills and knowledge needed to succeed in the industry.
Investment in Health and Research
Amgen Singapore Manufacturing is committed to investing in health and research to improve patient services and support services. The company’s investment in research and development has resulted in biotechnology breakthroughs that have the potential to change the face of medicine. Amgen Singapore’s investment in the biomedical industry has also helped to position Singapore as a hub for biopharmaceutical manufacturing and research.
During the Covid-19 pandemic, Amgen Singapore Manufacturing stepped up to support the local community. The company donated funds and resources to support Covid-19 relief efforts and provided support to frontline workers. Amgen Singapore also continued to invest in research and development to improve patient outcomes and develop new treatments for a range of medical conditions.
Overall, Amgen Singapore Manufacturing is making a significant contribution to the community and the economy. By investing in high school education and workforce development, the company is helping to create a skilled workforce that can support the biomedical industry in Singapore. And by investing in research and development, Amgen Singapore is helping to improve patient outcomes and develop new treatments that have the potential to change lives.
Frequently Asked Questions
What career opportunities are available at Amgen’s Singapore manufacturing facility?
Amgen Singapore Manufacturing is always on the lookout for talented individuals who share their commitment to innovation and excellence. You can explore the current job openings on their website, where you will find a variety of roles in manufacturing, quality assurance, engineering, and more.
How can one apply for an internship at Amgen in Singapore?
Amgen Singapore Manufacturing offers internships to students who are interested in gaining hands-on experience in the biotechnology industry. You can visit their website to find out more about their internship programs and the application process.
Which products are produced at Amgen’s manufacturing site in Singapore?
Amgen Singapore Manufacturing produces a range of biologic medicines that are used to treat serious illnesses such as cancer, rheumatoid arthritis, and osteoporosis. Some of the products manufactured at the site include Enbrel, Neulasta, and Prolia.
What is the address of Amgen’s manufacturing facility in Singapore?
Amgen Singapore Manufacturing is located at 1 Tuas South Avenue 6, Singapore 637021.
How does Amgen’s Singapore manufacturing site contribute to the global operations?
Amgen Singapore Manufacturing is a key part of Amgen’s global manufacturing network. The site plays a critical role in meeting the growing demand for biologic medicines in the Asia-Pacific region and beyond.
What are the experiences of employees working at Amgen Singapore, according to Glassdoor reviews?
According to Glassdoor reviews, employees at Amgen Singapore Manufacturing appreciate the company’s focus on innovation and its commitment to employee development. They also value the company’s culture of collaboration and teamwork, which fosters a supportive and inclusive work environment.